Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: Clin Nucl Med. 2020 Apr;45(4):267–275. doi: 10.1097/RLU.0000000000002967

Figure 3:

Figure 3:

Association between pre-therapy FLT-PET vs. CT objective response at 12 weeks. A) Baseline markers in FLT-PET include PTV, BLR, and SUV. Delta-biomarkers are calculated as the change from baseline to 6 weeks. B) Responders have a trend towards greater BLR at baseline and lower PTV at baseline. C) Responders have a trend toward lower delta-PTV compared to non-responders.